Kidney injury risk soars with ‘triple whammy’ drug combo
By
Alicia Lasek (f3)
May 12, 2022
When taken together, commonly indicated drugs may lead to acute kidney injury in susceptible patients with high blood pressure, a new study finds.
COVID-19-related neuropsychiatric conditions mirror those of other respiratory illnesses, study finds
By
Alicia Lasek (f3)
May 12, 2022
Disease severity, not pathogen type, is key when treating neuropsychiatric complications after respiratory illness, a new study finds.
AHCA/NCAL, 15 other groups pressure HHS to extend public health emergency
By
Lois A. Bowers
May 12, 2022
Sixteen national organizations were thinking of fall and the flu Tuesday when they asked HHS Secretary Xavier Becerra to extend the public health emergency related to COVID-19.
One in three Alzheimer, dementia cases tied to modifiable risk factors
May 11, 2022
Midlife obesity, physical inactivity and low education are three prominent modifiable risk factors tied to dementia, researchers say.
Clinical briefs for Thursday, May 12
By
Alicia Lasek (f3)
May 12, 2022
NHSN vaccine reporting deadline coming May 16 … FDA advisers to consider expanding use of Parkinson’s drug Nuplazid to treat Alzheimer’s psychosis … COVID-19 has become less deadly during the pandemic...
DaVita exec skeptical pandemic is receding
By
Diane Eastabrook
May 11, 2022
The chief financial officer for global dialysis provider DaVita Health is throwing cold water on the notion that the COVID-19 pandemic is ending anytime soon.
LeadingAge’s president and CEO has asked Congress to ensure access to COVID-19 tests, vaccines and treatments in letters supporting the White House’s request for COVID-19 supplemental funds.
Poor vision may lead to faulty diagnoses of mild cognitive impairment: study
By
Alicia Lasek (f3)
May 11, 2022
Unaddressed vision problems may skew the results of cognitive tests and lead to inaccurate diagnoses of mild cognitive impairment, researchers say.
Delusions directly impact quality of life for nursing home residents with dementia
By
Alicia Lasek (f3)
May 10, 2022
Delusions and hallucinations require targeted treatments that take other neuropsychiatric symptoms into account to improve quality of life, a new study finds.
The impact of chronic disease and the inequitable burden of COVID-19 must be addressed as the U.S. moves into a new pandemic phase, two experts contend.